Challenging the pipeline

Area of Science:

• Biomedical research
• Drug discovery and development
• Translational medicine

Background:

• Traditional drug discovery relies heavily on animal models and in vitro assays.
• These methods often fail to accurately predict human responses, leading to high attrition rates.
• A paradigm shift is needed to enhance the predictive power of preclinical models.

Discussion:

• Proposes a hypothetical drug discovery program centered on human- and disease-relevant models.
• Emphasizes integrating systems biology, omics data, and advanced computational approaches.
• Advocates for a holistic strategy from target identification to clinical validation.

Key Insights:

• Human-relevant models are crucial for improving drug efficacy and safety predictions.
• Prioritizing these models can streamline the drug development pipeline.
• This approach necessitates a multidisciplinary collaboration and innovative technological integration.

Outlook:

• Potential to accelerate the delivery of effective therapeutics to patients.
• Could reduce the cost and failure rate associated with drug development.
• Sets the stage for future research into optimized, human-centric drug discovery frameworks.